Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats

Hypertension Research

Volumn 20, Issue 3, 1997, Pages 183-192

  Vaskonen, Timo ^a   Mervaala, Eero ^a   Krogerus, Leena ^b   Teräväinen, Terttu Liisa ^a   Laakso, Juha ^c   Karppanen, Heikki ^a   Vapaatalo, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Maria Hospital   (Finland)

^c Mila Ltd   (Finland)

Author keywords

Blood pressure; Endothelium; Heart infarction; Kidney damage; L NAME; SHR; Sodium

Indexed keywords

ACETYLCHOLINE; ARGININE METHYL ESTER; CREATININE; NITRIC OXIDE; NORADRENALIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CREATININE BLOOD LEVEL; HEART HYPERTROPHY; HEART INFARCTION; KIDNEY HYPERTROPHY; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PROTEINURIA; RAT; SALT INTAKE; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; CREATININE; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HYPERTENSION; KIDNEY; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN SIZE; PROTEINURIA; RATS; RATS, INBRED SHR; RENIN; SODIUM CHLORIDE, DIETARY; WEIGHT GAIN;

EID: 0030659834     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.183     Document Type: Article

References (46)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
2. Rees DD, Palmer RMJ, Schulz R, et al: Characterization of three inhibitors of endothelial nitric oxide synthesis in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
3. G-nitro-L-arginine methyl ester. J Hypertens 1991; 9 (Suppl 6): S192-S193.
4. Arnal J-F, Battle T, Menard J, Michel J-B: The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rat. J Hypertens 1993; 11: 945-950.
5. Morton JJ, Beattie EC, Speirs A, Gulliver F: Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens 1993; 11: 1083-1088.
6. Navarro J, Sanchez A, Saiz J, et al: Hormonal, renal and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol 1994; 267: R1516-R1521.
7. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375-3378.
8. Salazar FJ, Alberola A, Pinilla JM, et al: Salt induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 1993; 22: 49-55.
9. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000.
10. Mervaala EMA, Himberg J-J, Laakso J, Tuomainen P, Karppanen H: Beneficial effects of a potassium-and magnesium-enriched salt alternative. Hypertension 1992; 19: 535-540.
11. Mervaala EMA, Laakso J, Karppanen H: Cardiovascular effects of felodipine are not antagonized by dietary salt. Eur J Pharmacol 1994a; 255: 73-79.
12. Mervaala EMA, Laakso J, Vapaatalo H, Karppanen H: Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative. Br J Pharmacol 1994b; 112: 640-648.
13. Mervaala EMA, Laakso J, Himberg JJ, Karppanen H: Replacement of regular salt by a novel salt alternative improves the cardiovascular effects of the ACE inhibitor enalapril. Hypertens Res 1994c; 17: 59-69.
14. Mervaala EMA, Paakkari I, Laakso J, et al: Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril. Br J Pharmacol 1994d; 111: 1189-1197.
15. Vaskonen T, Mervaala E, Laakso J, Sievinen E, Karppanen H: Interrelationships between salt and fish oil in stroke prone spontaneously hypertensive rat. Blood Pressure 1996; 5: 178-189.
16. Frost CD, Law MR, Wald NJ: By how much does dietary salt reduction lower blood pressure? II - Analysis of observational data within populations. Br Med J 1991; 302: 815-818.
17. Law MR, Frost CD, Wald NJ: By how much does dietary salt reduction lower blood pressure? I - Analysis of observational data among populations. Br Med J 1991; 302: 811-815.
18. Law MR, Frost CD, Wald NJ: By how much does dietary salt reduction lower blood pressure? III - Analysis of data from trials of salt reduction. Br Med J 1991; 302: 819-824.
19. Dyer AR, Shipley M, Elliot P: Urinary electrolyte excretion in 24 hours and blood pressure in the INTERSALT study. I. Estimate of reliability. II. Estimate of electrolyte-blood pressure associations corrected for regression dilution bias. Am J Epidemiol 1994: 139: 927-951.
20. McGormick CP, Rauch AL, Buckalew Jr WM: Differential effect of dietary salt on renal growth in Dahl salt-sensitive and salt-resistant rats. Hypertension 1989; 13: 122-127.
21. Mervaala EMA, Laakso J, Vapaatalo H, Karppanen H: Effects of enalapril and hydrochlorothiazide on the salt-induced cardiac and renal hypertrophy in normotensive rats. Naunyn Schmiedebergs Arch Pharmacol 1994e; 350: 416-425.
22. Shultz PJ, Tolins JP: Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J Clin Invest 1993; 91: 642-650.
23. Tolins JP, Shultz PJ: Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994; 46: 230-236.
24. Ruilope LM, Lahera V, Rodicio JL, Romero JC: Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens 1994; 12: 625-631.
25. Yamori Y, Horie R, Akiguchi I, Kihara M, Nara Y, Lovenberg W: Symptomatological classification in the development of stroke in stroke-prone spontaneously hypertensive rats. Jpn Circ J 1982; 46: 274-283.
26. Pörsti I, Arvola P, Vuorela H, et al: Effects of a high calcium diet and deoxycorticosterone on vascular smooth muscle responses in spontaneously hypertensive rats. J Hypertens 1991; 8: 835-841.
27. Kähönen M, Arvola P, Vapaatalo H, Pörsti I: Comparison of cumulative and non-cumulative administration of vasoactive agents in arterial smooth muscle responses in vitro. Pharmacol Toxicol 1993; 73: 142-145.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
29. Baylis CB, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 258.
30. Moreno H Jr, Metze K, Antunes E, Zatz R, De Nucci G: Chronic nitric oxide blockade causes cardiac ischemia but not cardiac hypertrophy: an experiment of four weeks in rats. Verh Dtsch Ger Path 1994; 78: 459.
31. Arnal J-F, Warin L, Michel J-B: Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992; 90: 647-652.
32. Deng LY, Thibault G, Schiffrin EL: Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens 1993; 15: 527-537.
33. Kobayashi Y, Ikeda K, Kakizoe E, et al: Comparison of vasopressor effects of nitro arginine in stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 1991; 18: 599-604.
34. + feeding in stroke-prone hypertensive rats. Hypertension 1990; 15: 318-326.
35. Fujihara CK, Michellazzo SM, de Nucci G, Zatz R: Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 1994; 266 (5pt2): F697-F705.
36. Deng X, Welch WJ, Wilcox CS: Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int 1994; 46: 639-646.
37. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL: Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension 1996; 27: 49-55.
38. Gardes J, Gonzales MF, Alchenc-Gelas F, Menard J: Influence of sodium diet on L-NAME effects on renin release and renal vasoconstriction. Am J Physiol 1994; 267: F798-F804.
39. Johnson RA, Freeman RH: Pressure natriuresis in rats during blockade of the L-arginine/nitric oxide pathway. Hypertension 1992; 19: 333-338.
40. Nagaoka A, Shino A, Shibota M: Implication of renal perfusion pressure in stroke prone spontaneously hypertensive rats. Am J Physiol 1980; 238: H317-H324.
41. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992; 20: 298.
42. Moreno H Jr, Nathan LP, Costa SKP, et al: Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol 1995; 287: 93-96.
43. Khraibi AA: Inhibition of nitric oxide causes exaggerated natriuresis in spontaneously hypertensive rats. Am J Physiol 1994; 266: F762-F766.
44. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 1991; 261: F1033-F1037.
45. Konishi M, Su C: Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983; 5: 881-886.
46. Lüscher TF, Raij L, Vanhouette PM: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9: 157-163.